Vimarsana
Biggest News Aggregation in the World

Page 9 - Infant Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Infant Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Infant Development Today - Breaking & Trending Today

Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study | DNA RNA and Cells - Vimarsana News

Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study | DNA RNA and Cells

Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study

New Study Finds Improved Long-Term Neurodevelopmental Outcomes for Extremely Premature Infants Fed Prolacta's Exclusive Human Milk Diet (EHMD) - Vimarsana News

New Study Finds Improved Long-Term Neurodevelopmental Outcomes for Extremely Premature Infants Fed Prolacta's Exclusive Human Milk Diet (EHMD)

/PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature...

New Study Finds Improved Long-Term Neurodevelopmental Outcomes for Extremely Premature Infants Fed Prolacta's Exclusive Human Milk Diet (EHMD) - Vimarsana News

New Study Finds Improved Long-Term Neurodevelopmental Outcomes for Extremely Premature Infants Fed Prolacta's Exclusive Human Milk Diet (EHMD)

Preterm Infants Who Received Prolacta's 100% Human Milk-Based Fortifiers as Part of an EHMD in the NICU Had Improved Developmental Outcomes at Age...

Europe OKs 1st one-dose drug to protect babies against RSV - Vimarsana News

Europe OKs 1st one-dose drug to protect babies against RSV

The European Commission has authorized the world’s first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year

Source: go.com
Association of birthweight centiles and early childhood development of singleton infants born from 37 weeks of gestation in Scotland: A population-based cohort study - Vimarsana News

Association of birthweight centiles and early childhood development of singleton infants born from 37 weeks of gestation in Scotland: A population-based cohort study

In a population-based cohort study in Scotland, Abiodun Adanikin and colleagues study the association of birthweight centiles and motor, communication, and social developmental concerns identified at ages 2 to 3.5 years of age.

Source: plos.org